Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2009 / Cilt: 17 - Sayı: 4

Determining the risk and frequecy of coronary artery disease in patients who have peripheric vascular occlusive disease and who will have vascular surgery

Periferik tıkayıcı arter hastalığı olan vasküler cerrahi uygulanacak hastalarda koroner arter hastalığı riskinin ve sıklığının belirlenmesi

Pages
261–266
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were significant differences between group 1a and group 1b with respect to fibrinogen and iron (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The purpose of our study was to observe risks and frequency of coronary artery disease (CAD) in patients who had peripheral occlusive vascular disease (POVD) but who did not have symptoms of CAD, to determine whether the severity and rate of atherosclerosis risk factors were different in these patients and whether it was possible to predict the concurrence of these diseases by means of tests.Methods: Seventy patients who underwent medical or surgical treatment because of CAD and POVD after May 2005 were enrolled in the study.
📊
Key Findings & Data:Patients with POVD was called group 1 and those who did not have POVD but only CAD were called group 2.
💡
Conclusion & Impact:There were significant differences between group 1a and group 1b with respect to fibrinogen and iron (p
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: The purpose of our study was to observe risks and frequency of coronary artery disease (CAD) in patients who had peripheral occlusive vascular disease (POVD) but who did not have symptoms of CAD, to determine whether the severity and rate of atherosclerosis risk factors were different in these patients and whether it was possible to predict the concurrence of these diseases by means of tests.Methods: Seventy patients who underwent medical or surgical treatment because of CAD and POVD after May 2005 were enrolled in the study. Patients with POVD was called group 1 and those who did not have POVD but only CAD were called group 2. Group 1 (n=44) was divided into two subgroups according to presence of additional CAD (group 1a, n=27) or absence of CAD (group 1b, n=17). There were 26 patients in group 2. Groups were compared with respect to age, gender, risk factors of atherosclerosis, C-reactive protein (CRP), fibrinogen, iron, ferritin.Results: Frequency of CAD in patients who had POVD was 61.36%. There was a significant difference between group 1 and 2 in terms of smoking and gender (p0.05). There was significant difference between group 1a and group 1b about CRP levels. C-reactive protein levels were also significantly different between group 1a and 2. There were significant differences between group 1a and group 1b with respect to fibrinogen and iron (p

Özet

Amaç: Çalışmamızda, periferik tıkayıcı arter hastalığı (PTAH) semptomlarıyla başvuran fakat koroner arter hastalığı (KAH) yönünden asemptomatik hastalarda, KAH görülme sıklığı ve riski, ateroskleroz risk faktörlerinin şiddet ve oranının bu hastalarda farklı olup olmadığı ve yapılacak testlerle bu hastalıkların birlikteliğinin öngörülüp görülemeyeceği araştırıldı.Çalışma planı: Mayıs 2005 tarihinden sonra PTAH ve KAH tanılarıyla kliniğimizde cerrahi ve tıbbi tedavi uygulanan 70 hasta çalışmaya alındı. Periferik tıkayıcı arter hastalığı semptomlarıyla başvuranlar grup 1, PTAH olmayıp sadece KAH olanlar grup 2 olarak adlandırıldı. Grup 1�de PTAH�ye eşlik eden KAH�si olanlar grup 1a, olmayanlar grup 1b olarak ayrıldı. Grup 1�de 44 hasta (grup 1a, n=27; grup 1b, n=17), grup 2�de ise 26 hasta vardı. Gruplar, yaş, cinsiyet, ateroskleroz risk faktörleri, C-reaktif protein (CRP), fibrinojen, demir, ferritin yönünden karşılaştırıldı.Bulgular: Periferik tıkayıcı arter hastalığı semptomlarıyla başvuranlarda, KAH görülme oranı %61.36 idi. Grup 1 ve 2 arasında, cinsiyet ve sigara kullanımı açısından anlamlı fark bulundu (p0.05). C-reaktif protein seviyesi açısından, grup 1a ile grup 1b arasında anlamlı fark vardı. C-reaktif protein seviyesi açısından grup 1a ile grup 2 arasında da anlamlı fark vardı. Fibrinojen ve demir değerleri açısından grup 1a ve 1b arasında anlamlı fark vardı (p

🔖

Cite This Article

KARAHAN, O., KATRANCIOĞLU, N., BERKAN, Ö., MANDUZ, Ş., TÜNEL, H. A. (2022). Determining the risk and frequecy of coronary artery disease in patients who have peripheric vascular occlusive disease and who will have vascular surgery. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 17 - Sayı: 4, 261–266. https://ajindex.com/articles/624666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Akgül E, Aydemir K. İnflamasyon ve ateroskleroz. Türk Kardiyoloji Seminerleri 2003;5:492-505
  2. Curb JD, Masaki K, Rodriguez BL, Abbott RD, Burchfiel CM, Chen R, et al. Peripheral artery disease and cardiovascular risk factors in the elderly: the honolulu heart program. Arteriosclerosis, Thrombosis, and Vascular Biology 1996; 16:1495-500
  3. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-7
  4. Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttila I, Rantanen T, et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001;33:37-47
  5. Zacharski LR, Chow B, Lavori PW, Howes PS, Bell MR, DiTommaso MA, et al. The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J 2000;139:337-45
  6. Hertzer NR. Basic data concerning associated coronary disease in peripheral vascular patients. Ann Vasc Surg 1987;1:616-20
  7. Hertzer NR. Fatal myocardial infarction following abdominal aortic aneurysm resection. Three hundred forty-three patients followed 6-11 years postoperatively. Ann Surg 1980; 192:667-73
  8. Jamieson WR, Janusz MT, Miyagishima RT, Gerein AN. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation 1982;66:I92-7
  9. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991;18:203-14
  10. Rutherford RB. Cardiac complications. In: Rutherford RB, editor. Vascular surgery. 4th ed. Vol. I, Chapter 31, Philadelphia: W. B. Saunders; 1995. p. 528-9
  11. Kozan Ö. Klinik epidemiyoloji, koroner risk faktörleri. In: Kozan Ö, editör. Akut koroner sendromlar el kitabı. İzmir: Erciyes Üniversitesi Yayınları; 2002. s. 7-29
  12. Ekici Y, Alaçayır İ. Arteriosklerozis obliterans. Türkiye Klinikleri Cerrahi Dergisi 2003;8:1-11
  13. Ascher E, Yorkovich WR. Bypasses to the plantar arteries and other branches of tibial arteries. In: Calligaro K, Pearce WH, Ricotta JJ, Moneta GL, Kent KC, editors. Haimovici�s vascular surgery. 5th ed. New York: Wiley, John & Sons; 2003. p. 582-6
  14. CDC. The health benefits of smoking cessation: a report of the Surgeon General,